Speaker:
Maria Saimbert, PharmD, PGY2 Oncology Pharmacy Resident, Geisinger - has nothing to disclose.
Moderator:
Tristan Maiers, PharmD, BCOP, PGY2 Oncology Pharmacy Director, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Identify risk factors for glioblastomas.
- Present signs and symptoms in patients that have a glioblastoma.
- Discuss the pharmacotherapy associated with treating glioblastoma.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Activity Director, Rajiv Panikkar, MD, Michele Long, MS, BSN, OCN, Jaime Weeder, CRNP, Christopher Kashi, PA-C and Caitlin McDonald, CPht, CVT have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA compliant.
Commerical Support for this Session
None.
Session date:
06/18/2024 - 7:00am to 8:00am EDT
Location:
Virtual using Microsoft Teams
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE
- 1.00 ACPE Tech
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit